Anxiety Clinical Trials in San Diego, CA

17 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Interoceptive Training Enhanced Mindfulness	N/A	Veterans Medical Research Foundation	<1 mi
Type I Hybrid Effectiveness-Implementation Trial of Primary Care Brief Mindfulness Training for Veterans	N/A	VA Office of Research and Development	<1 mi
Mechanisms of Exposure Therapy for OCD	N/A	Mclean Hospital	<1 mi
Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)	Phase 2/3	University of California, San Diego	<1 mi
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder	Phase 3	Vanda Pharmaceuticals	<1 mi
Pramipexole to Enhance Social Connections	Phase 2	University of California, San Diego	<1 mi
Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder	N/A	VA Office of Research and Development	<1 mi
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder	Phase 2	Intra-Cellular Therapies, Inc.	<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	<1 mi
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder	Phase 2	AbbVie	8 mi
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)	Phase 3	Definium Therapeutics US, Inc.	11 mi
Meditative Neurofeedback for Depression	N/A	University of California, San Diego	11 mi
Weighted Blankets for Postsurgical Pain	N/A	University of California, San Diego	11 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	36 mi
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)	Phase 3	VistaGen Therapeutics, Inc.	36 mi
A Study of NTX-1472 in Social Anxiety Disorder	Phase 2	Newleos Therapeutics, Inc.	36 mi
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder	Phase 2	Intra-Cellular Therapies, Inc.	36 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.